MTHFR Arg594Gln influenced OS with HR associated with carrier status being 0.68 (95% CI: 0.46–1.00), and 0.60 (95% CI: 0.37–0.95) in all lung cancer and NSCLC, respectively. Here, MTHFR is linked to non-small cell lung carcinoma.